Add your Event List View →

Events Calendar (May 2023)

March 4 April 4 May 3 June 1 July August September 1 October November December January February
 
May
Monday Tuesday Wednesday Thursday Friday Saturday Sunday
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
CGT Manufacturing 2023

CGT Manufacturing 2023

Oxford Global’s Cell & Gene Therapy Manufacturing and Supply Chain Congress aim to address key bottlenecks within the supply and manufacture of cell and gene therapies globally. Taking place on the 10-11th May 2023, Ireland Dublin, the event aims to bring together key industry leaders in Ireland the hub of cell and gene therapy manufacturing investment. 

Hear case studies on the cell and gene therapy landscape in Ireland, and the development of new manufacturing facilities. Presentations will showcase both viral and non-viral vector engineering and the acceleration of analytical tools and techniques to speed up process development, as well as streamlining CGT manufacture. 

Connect with over 150 attendees and benefit from 20+ presentations and interactive sessions covering the sustainability and automation of supply chains. Engage in valuable discussion on meeting regulatory requirements and solving CMC challenges to improve process development. 

Key Speakers include:

  • Sarah Thomas, Senior Vice President, Quality, Regenixbio  
  • Guy McDonell, Senior Director, Global Technology & Engineering, Pfizer  
  • Kenneth Green, Senior Director, Vertex Pharmaceuticals 
  • Shilpi Rajoria, Director QC Analytical Testing, Bristol Myers Squibb 
  • Darrin Morrissey, Chief Executive Officer, National Institute for Bioprocessing Research & Training 

 

Engage in solution-oriented dialogue with 15+ vendor companies over 2-days over multiple networking breaks with the opportunity to meet 1-2-1 and eliminate the challenges you face.   

Do not miss this opportunity to engage with like-minded peers in the heart of Ireland to further your understanding of the cell and gene manufacturing. For more information, please contact h.liddiard@oxfordglobal.co.uk. 

11
CGT Manufacturing 2023

CGT Manufacturing 2023

Oxford Global’s Cell & Gene Therapy Manufacturing and Supply Chain Congress aim to address key bottlenecks within the supply and manufacture of cell and gene therapies globally. Taking place on the 10-11th May 2023, Ireland Dublin, the event aims to bring together key industry leaders in Ireland the hub of cell and gene therapy manufacturing investment. 

Hear case studies on the cell and gene therapy landscape in Ireland, and the development of new manufacturing facilities. Presentations will showcase both viral and non-viral vector engineering and the acceleration of analytical tools and techniques to speed up process development, as well as streamlining CGT manufacture. 

Connect with over 150 attendees and benefit from 20+ presentations and interactive sessions covering the sustainability and automation of supply chains. Engage in valuable discussion on meeting regulatory requirements and solving CMC challenges to improve process development. 

Key Speakers include:

  • Sarah Thomas, Senior Vice President, Quality, Regenixbio  
  • Guy McDonell, Senior Director, Global Technology & Engineering, Pfizer  
  • Kenneth Green, Senior Director, Vertex Pharmaceuticals 
  • Shilpi Rajoria, Director QC Analytical Testing, Bristol Myers Squibb 
  • Darrin Morrissey, Chief Executive Officer, National Institute for Bioprocessing Research & Training 

 

Engage in solution-oriented dialogue with 15+ vendor companies over 2-days over multiple networking breaks with the opportunity to meet 1-2-1 and eliminate the challenges you face.   

Do not miss this opportunity to engage with like-minded peers in the heart of Ireland to further your understanding of the cell and gene manufacturing. For more information, please contact h.liddiard@oxfordglobal.co.uk. 

12
13
14
15
16
17
18
19
20
21
22
23
24
25
9th Annual Formulation & Drug Delivery Congress

9th Annual Formulation & Drug Delivery Congress

Learn from and meet leading experts in pharmaceutical science, addressing the critical strategic advances and technical innovation in formulation, drug delivery and drug product development.

Agenda at a Glance

Day One

Track 1: Improving Small Molecule Drug Formulation

  • Technologies and processes advancing drug product development
  • Stability challenges and solutions
  • Characterisation, solid state
  • Drug solubility enhancement
  • Fast-track formulation

Track 2: Advanced Biologics Drug Delivery

  • Innovative delivery for biologics
  • Protein, peptide & mAb delivery
  • Long-acting injectable forms
  • Novel delivery methods for fragile molecules
  • Advanced Therapeutics – cell & gene therapies
  • Nanoparticle delivery

Track 3: Stability, Bioanalysis & Characterisation

  • Drug product development
  • Supersaturation of insoluble molecules
  • Characterisation of fragile molecule
  • Bioanalytics improving drug product development

Day Two

Track 1: Biotherapeutic Formulation Development

  • Parenteral formulations
  • Drug optimisation (safety & efficacy)
  • Biotherapeutic characterisation
  • Lifecycle management of biotherapeutics
  • Continuous processing for complex products
  • Formulation for advanced therapies

Track 2: Small Molecule Drug Delivery Techniques & Technologies

  • Oral dosage form improvement
  • Injection/infusion
  • Transdermal & dermally applied drugs
  • Combination products & devices
  • Patient-friendly delivery and dosage forms
8th Annual Inhalation & Respiratory Drug Delivery Congress

8th Annual Inhalation & Respiratory Drug Delivery Congress

Discover novel case studies on the latest challenges and innovations in inhaled therapy formulation and drug delivery. Featuring in-depth presentations focusing on a variety of established and emerging therapeutic areas (including inhaled biologics), and advancements in inhalation devices and combination products.

Day 1 – Formulation Development For Inhaled Therapies

  • Aerosol Science
       » Characterising aerosol dynamics
       » Particle engineering
  • Increasing Drug Retention In The Lung
  • Formulation & Characterisation Of DPIs
  • Design And Development Of Novel Formulations/Therapies

Day 2 – Application Areas of Inhaled Therapies, Delivery & Device Development

  • Case studies from alternative therapeutic areas:
       » Inhaled biologics
       » Inhalation of new modalities, mRNA, siRNA
       » Inhaled Vaccines
  • Inhalation therapy applications for systemic diseases
  • Novel technologies for pulmonary & nasal delivery
  • Device development, improving inhaler techniques
       » Digital devices, connected health
  • Systemic versus local inhalable treatments
26
9th Annual Formulation & Drug Delivery Congress

9th Annual Formulation & Drug Delivery Congress

Learn from and meet leading experts in pharmaceutical science, addressing the critical strategic advances and technical innovation in formulation, drug delivery and drug product development.

Agenda at a Glance

Day One

Track 1: Improving Small Molecule Drug Formulation

  • Technologies and processes advancing drug product development
  • Stability challenges and solutions
  • Characterisation, solid state
  • Drug solubility enhancement
  • Fast-track formulation

Track 2: Advanced Biologics Drug Delivery

  • Innovative delivery for biologics
  • Protein, peptide & mAb delivery
  • Long-acting injectable forms
  • Novel delivery methods for fragile molecules
  • Advanced Therapeutics – cell & gene therapies
  • Nanoparticle delivery

Track 3: Stability, Bioanalysis & Characterisation

  • Drug product development
  • Supersaturation of insoluble molecules
  • Characterisation of fragile molecule
  • Bioanalytics improving drug product development

Day Two

Track 1: Biotherapeutic Formulation Development

  • Parenteral formulations
  • Drug optimisation (safety & efficacy)
  • Biotherapeutic characterisation
  • Lifecycle management of biotherapeutics
  • Continuous processing for complex products
  • Formulation for advanced therapies

Track 2: Small Molecule Drug Delivery Techniques & Technologies

  • Oral dosage form improvement
  • Injection/infusion
  • Transdermal & dermally applied drugs
  • Combination products & devices
  • Patient-friendly delivery and dosage forms
8th Annual Inhalation & Respiratory Drug Delivery Congress

8th Annual Inhalation & Respiratory Drug Delivery Congress

Discover novel case studies on the latest challenges and innovations in inhaled therapy formulation and drug delivery. Featuring in-depth presentations focusing on a variety of established and emerging therapeutic areas (including inhaled biologics), and advancements in inhalation devices and combination products.

Day 1 – Formulation Development For Inhaled Therapies

  • Aerosol Science
       » Characterising aerosol dynamics
       » Particle engineering
  • Increasing Drug Retention In The Lung
  • Formulation & Characterisation Of DPIs
  • Design And Development Of Novel Formulations/Therapies

Day 2 – Application Areas of Inhaled Therapies, Delivery & Device Development

  • Case studies from alternative therapeutic areas:
       » Inhaled biologics
       » Inhalation of new modalities, mRNA, siRNA
       » Inhaled Vaccines
  • Inhalation therapy applications for systemic diseases
  • Novel technologies for pulmonary & nasal delivery
  • Device development, improving inhaler techniques
       » Digital devices, connected health
  • Systemic versus local inhalable treatments
27
28
29
30
31
1
2
3
4
5
<< April June >>

← Back to List of Events

SHARE